We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ConocoPhillips (COP - Free Report) has received consent from board of directors for increasing share repurchase program for 2018 by 50% to $3 billion from $2 billion. In 2018, the company will have sufficient cash from operations to fund the program along with dividend and capital expenditures.
Currently, the company has a total share repurchase authorization of $6 billion. The 2018 share repurchase program expansion to $3 billion along with shares repurchased worth $3 billion during 2016 and 2017, will fully utilize the board’s existing authorization. Therefore, the board has authorized additional share repurchases of $9 billion, taking the total amount to $15 billion.
In late 2016, ConocoPhillips had commenced the current share repurchase program. The $15-billion authorization reflects about 20% of the total shares outstanding as of Sep 30, 2016. This comprises shares already repurchased under this program as well as future repurchases based on the current share price.
ConocoPhillips also announced that it has reduced debt by $2.1 billion during the second quarter and has attained declared debt target of $15 billion much before the original target date of 2019 end.
The board of directors holds the discretionary power to execute the repurchase authorization. The level or rate of activity may be impacted by future earnings, financial condition, capital requirements, levels of indebtedness, credit ratings and other considerations that are relevant.
These initiatives emphasize the company’s commitment toward boosting shareholders’ value. It also highlights the fact that the company projects upside potential in shares. As the company achieved the target of meeting debt before the targeted date, ConocoPhillips can focus on channeling cash flows toward business growth and maintain efficiency in operations.
As oil and gas prices continue to recover, several oil giants have reinitiated share repurchase program, which is intended to increase shareholders’ value. Some of these companies include BP plc (BP - Free Report) and Anadarko Petroleum Corporation
Price Performance
In the past three months, ConocoPhillips’ shares have gained 8.7% compared with the industry’s rise of 8.5%.
Occidental Petroleum is an international oil and gas exploration and production company. It pulled off an average positive earnings surprise of 30.2% in the last four quarters.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Conoco (COP) Hikes Share Repurchase Program, Lowers Debt
ConocoPhillips (COP - Free Report) has received consent from board of directors for increasing share repurchase program for 2018 by 50% to $3 billion from $2 billion. In 2018, the company will have sufficient cash from operations to fund the program along with dividend and capital expenditures.
Currently, the company has a total share repurchase authorization of $6 billion. The 2018 share repurchase program expansion to $3 billion along with shares repurchased worth $3 billion during 2016 and 2017, will fully utilize the board’s existing authorization. Therefore, the board has authorized additional share repurchases of $9 billion, taking the total amount to $15 billion.
In late 2016, ConocoPhillips had commenced the current share repurchase program. The $15-billion authorization reflects about 20% of the total shares outstanding as of Sep 30, 2016. This comprises shares already repurchased under this program as well as future repurchases based on the current share price.
ConocoPhillips also announced that it has reduced debt by $2.1 billion during the second quarter and has attained declared debt target of $15 billion much before the original target date of 2019 end.
The board of directors holds the discretionary power to execute the repurchase authorization. The level or rate of activity may be impacted by future earnings, financial condition, capital requirements, levels of indebtedness, credit ratings and other considerations that are relevant.
These initiatives emphasize the company’s commitment toward boosting shareholders’ value. It also highlights the fact that the company projects upside potential in shares. As the company achieved the target of meeting debt before the targeted date, ConocoPhillips can focus on channeling cash flows toward business growth and maintain efficiency in operations.
As oil and gas prices continue to recover, several oil giants have reinitiated share repurchase program, which is intended to increase shareholders’ value. Some of these companies include BP plc (BP - Free Report) and Anadarko Petroleum Corporation
Price Performance
In the past three months, ConocoPhillips’ shares have gained 8.7% compared with the industry’s rise of 8.5%.
Zacks Rank & Another Stock to Consider
ConocoPhillips currently sports a Zacks Rank #1 (Strong Buy). Another top-ranked player in the same sector is Occidental Petroleum Corporation (OXY - Free Report) , flaunting a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Occidental Petroleum is an international oil and gas exploration and production company. It pulled off an average positive earnings surprise of 30.2% in the last four quarters.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>